Musk’s company aims to soon test brain implant in people
Elon Musk’s Neuralink is one of many groups working on linking brains to computers, efforts aimed at helping treat brain disorders, overcoming brain injuries and other applications.
Bioscience
Inotiv plans to close two Indianapolis facilities in consolidation
The pharmaceutical testing company said it plans to close two isolator facilities in Indianapolis and consolidate them with existing facilities in the United States.
Corteva buys Houston-based plant biologics company for $1.2B
The acquisition is designed to accelerate Indianapolis-based Corteva’s biologicals business and make it one of the largest players in the market.
MBX Biosciences closes on $115M in drug-development funding
The funding amount is one of the largest in recent years for an Indiana-based science startup.
Noblesville leaders expand scope of planned Innovation Mile
City leaders expect a stretch of undeveloped agricultural land on the city’s southeast side to become Hamilton County’s next epicenter of innovation.
Business accelerator Gener8tor announces members of latest cohort for agbioscience accelerator
This year’s cohort for Gener8tor’s gBETA agbioscience accelerator includes companies working in everything from cold storage to aquaculture. The program wraps up later this month.
Purdue project to develop treatment for deadly brain cancer wins $398,000 in federal funding
Three Indiana institutions are teaming up to try to develop a treatment for glioblastoma, a lethal cancer that begins with the brain or spinal cord, and is difficult to treat, often requiring a combination of surgery, chemotherapy and radiation.
Elanco unveils plans for new ‘epicenter of animal health innovation’
| and 
John Russell
John Russell Elanco Animal Health Inc. on Tuesday broke ground and shared new designs for its planned $100 million-plus global headquarters at the former General Motors Stamping Plant site just west of downtown Indianapolis.
Scientists finally finish decoding entire human genome
Scientists said this full picture of the genome will give humanity a greater understanding of our evolution and biology while also opening the door to medical discoveries in areas like aging, neurodegenerative conditions, cancer and heart disease.
16 Tech promotes Emily Krueger to chief executive
Krueger currently serves as chief operating officer at the 16 Tech Community Corp., which oversees the 50-acre 16 Tech Innovation District on the city’s near-west side.
Cook Medical to sell reproductive health unit for $875M
The reproductive health unit includes products for obstetrics and gynecology, in vitro fertilization and assisted reproductive technology.
Initiative aims to spur innovation by connecting, analyzing data bases
Fueled with a $36 million Lilly Endowment Inc. grant, the Central Indiana Corporate Partnership has launched AnalytiXIN to promote innovations in data science throughout Indiana.
Lilly signs deal with California biotech to develop treatments for Lou Gehrig’s disease
The collaboration could be worth as much as $694 million and potential royalties to Verge Genomics if the two companies hit development milestones.
Quantigen Biosciences plans Fishers expansion, 30 new jobs
Fishers-based Quantigen Biosciences is spending $2.5 million to redevelop 40,000 square feet of office space along Interstate 69 as its new specialty contract research laboratory.
Corteva to pay $640M as part of agreement over ‘forever chemicals’
The chemicals at issue are known as per- and polyfluoroalkyl substances, or PFAS. They include perfluorooctanoic acid, which was used in the production of Teflon, firefighting foam, water-repellent clothing and many other household and personal items.
No longer sleepy and small, Elanco marks transformation with new HQ
CEO Jeff Simmons said the company’s high-profile downtown Indianapolis headquarters will signal a cultural transformation at the company, which for most of its six decades of existence operated as a little-noticed subsidiary of Eli Lilly and Co.
Court orders FDA to assess environmental impact of modified salmon
The ruling centers on AquaBounty’s salmon, which are genetically modified to grow faster than normal salmon. After clearing other regulatory hurdles. AquaBounty began growing the fish in indoor tanks at an Indiana plant last year.
Fishers council OKs $10M in incentives for biopharm firm, Maple Del development
The Fishers City Council on Monday approved two economic development deals that are expected to lead to a combined $96 million in investment.
Scioto Biosciences lands $26.5 million from Korean biotech
The Indianapolis-based startup is developing drugs targeting brain and bowel disorders.
16 Tech announces names for innovation hub, artisan marketplace
The innovation hub, expected to open early next year, is part of a $500 million, 50-acre campus along Indiana Avenue. The hub’s new name is a nod to the site’s history as the former Citizens Water headquarters.